Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

CEO Christopher Weber Trims Takeda’s Fat and Builds Muscle in Much-Needed Areas

Takeda Pharmaceutical is a little bit closer to grabbing some necessary cash by unloading its stake in the chemicals business Wako Pure Chemical Industries Ltd.

Read More »

Bone Therapeutics Taps New CEO

Shares of Bone Therapeutics dropped slightly after the company announced a change in leadership and ended plans to hold a clinical trial in the United States.

Read More »

Little Celldex is Sitting on Plenty of Cash and is Ready to Go Shopping

Hampton, N.J.-based Celldex Therapeutics announced recently that it planned to acquire Kolltan Pharmaceuticals. In addition to the news from its third-quarter 2016 financial report, the company indicated it had $203.2 million in cash, cash equivalents and marketable securities at the end of the third quarter. Is this a hint the company will do more acquisitions?

Read More »

Monthly cost of providing key drugs could be $1-2 per person: experts

Essential medicines could be provided for as little as $1-$2 a month per person in developing countries, experts said as they called on governments to boost efforts to ensure everyone can access basic healthcare.

Read More »

Childhood cancer survivors have lasting health problems even with newer treatments

Despite advances that have made treatments safer and more effective, childhood cancer survivors do not appear to have experienced gains in long-term health outcomes, a new study suggests.

Read More »

Stanford uses CRISPR to correct sickle cell

Scientists at Stanford University School of Medicine have used the CRISPR gene-editing tool to repair the gene that causes sickle cell disease in stem cells.

Read More »

Three U.S. senators ask Mylan for EpiPen military reimbursements

Three members of the U.S. Senate Judiciary Committee said Mylan NV appears to have greatly overcharged the military for its lifesaving allergy treatment EpiPen.

Read More »

WHO doubles recommended number of health visits during pregnancy

The World Health Organization revised guidelines on antenatal care, saying pregnant women should have twice as many contacts with health providers – eight – as it recommended previously.

Read More »

Merck KGaA Staffers Demand Severance Payments

As Merck KGaA winds up its business operations in Pakistan, employees are demanding appropriate severance pay for long-time service to the German-based company Dawn, Pakistan’s oldest English-language newspaper reported.

Read More »

Biogen, Ionis Stocks Jump on Positive Study Data

Biogen and Ionis Pharma announced that Spinraza (nusinersen) met its primary endpoint in its Phase III trial in later-onset spinal muscular atrophy (SMA).

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

October 2019 Focus: Top 50 Company Profiles & Financials, Outcomes Creativity Index, and more!


Ad Right Bottom